Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
Clinical trial NCT05303857 · COMPLETED
Trial details
- NCT number
- NCT05303857
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-03
- Primary completion
- 2023-12-15
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.